Literature DB >> 1564937

Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation?

M Holmberg1.   

Abstract

The probability that ionizing radiation induces a t(9;22) reciprocal translocation with its break points confined to the same regions as the break points for the Philadelphia (Ph') translocation in chronic myelogenous leukemia (CML) has been calculated to be 7 x 10(-12) per cell and gray. This figure was used to estimate the number of individuals among the atomic bomb survivors at Hiroshima and Nagasaki with such an induced translocation. For 9196 atomic bomb survivors who received a mean organ dose equivalent to bone marrow of 0.85 sievert, the estimate is done that the number of individuals with a radiation-induced t(9;22) translocation in one of the pluripotent stem cells in bone marrow is of the order of 50. The observed number of affected individuals with CML within the same cohort is 18. Even if the estimate of the number of individuals has relatively large errors, this indicates that the primary event in the radiation-induced CML cases can be a radiation-induced t(9;22) reciprocal translocation.

Entities:  

Mesh:

Year:  1992        PMID: 1564937     DOI: 10.1016/0145-2126(92)90134-s

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

Review 1.  Quantitative modeling of chronic myeloid leukemia: insights from radiobiology.

Authors:  Tomas Radivoyevitch; Lynn Hlatky; Julian Landaw; Rainer K Sachs
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

2.  Chronic myelogenous leukemia and exposure to ionizing radiation--a retrospective study of 443 patients.

Authors:  A Corso; M Lazzarino; E Morra; S Merante; C Astori; P Bernasconi; M Boni; C Bernasconi
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

3.  A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.

Authors:  Sunhyun Ahn; Joon Seong Park; Jae Ho Han; Sung Ran Cho
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

4.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.